Scientists test if breakfast changes a cancer Drug's power
NCT ID NCT06075277
Summary
This early-stage study tested how eating food affects the body's absorption of an experimental cancer drug called BI 1810631 (Zongertinib). Sixteen healthy men took a single dose of the drug once after fasting and once after a meal. The goal was to see if food changes how much of the drug gets into the bloodstream, which helps researchers plan how to give the drug in future patient trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Berlin GmbH
Berlin, 13627, Germany
Conditions
Explore the condition pages connected to this study.